RNS News

Home/RNS News/

GE Healthcare launches new ultrasound AI software

Intelligent Ultrasound (AIM: MED), the artificial intelligence (AI) based ultrasound software and simulation company, today announced that GE Healthcare has launched its new AI-enhanced Women’s Health ultrasound system, Voluson SWIFT*. The Voluson SWIFT features SonoLyst, the world’s first fully integrated AI tool that recognizes the 20 views recommended by the International Society of Ultrasound in Obstetrics and Gynaecology mid-trimester practice guidelines for fetal imaging and incorporates Intelligent Ultrasound’s ScanNav Assist AI technology. MED GE Launch (30.09.20)

September 30th, 2020|

Change of registered office

Intelligent Ultrasound Group plc (AIM: MED), the ultrasound artificial intelligence (AI) software and simulation company, announces that it has changed its registered address to Floor 6A, Hodge House, 114-116 St Mary Street, Cardiff, CF10 1DY with immediate effect. MED - Change of Registered Office (21.09.20)

September 21st, 2020|

FDA filing submitted for second ScanNav AI software

Intelligent Ultrasound (AIM: MED), the artificial intelligence (AI) based ultrasound software and simulation company, announces that it has submitted its De Novo filing to the US Food & Drug Administration (‘FDA’) for its ScanNav AnatomyGuide Peripheral Nerve Block (PNB) artificial intelligence-based software. MED FDA submission (18.09.20)

September 18th, 2020|

Formation of Nomination Committee

Intelligent Ultrasound (AIM: MED), the artificial intelligence (AI) based ultrasound software and simulation company, announces the formation of a Nomination Committee of The Board of Directors. While to date, Intelligent Ultrasound has used the whole board to consider matters of nomination, given the Company’s current maturity and the nature of its current board composition, the Company is establishing a more focused Nomination Committee to lead its process for appointments and oversee the development of a diverse pipeline for succession. Formation of Nomination Committee (16.09.20)

September 16th, 2020|

Half Year Results 2020

Intelligent Ultrasound (AIM: MED), the artificial intelligence (AI) based ultrasound software and simulation company, announces its unaudited half year results to 30 June 2020. Despite the global impact of Covid19, the Company reduced its EBITDA¹ loss to £1.2m (H1 2019: loss of £1.3m) on a reduced revenue of £2.5m (H1 2019: £3.1m) and continued to successfully progress the development of four AI software products.   MED - interims RNS (06.08.20)

August 6th, 2020|

Notice of interim results

Intelligent Ultrasound Group plc (LSE: MED), the ultrasound artificial intelligence (AI) software and simulation company, announces it will issue its interim results for the six months ended 30 June 2020 on Thursday, 6 August 2020. The Company will host a briefing for analysts via ZOOM at 9.30am on Thursday, 6 August. If you would like to register to dial in to the analyst briefing or require further information, please contact Walbrook PR on 020 7933 8780 or email intelligentultrasound@walbrookpr.com. MED - notice of results (03.08.20)

August 3rd, 2020|

Half Year Trading Update

Intelligent Ultrasound Group plc (AIM: MED), the artificial intelligence (AI) based ultrasound software and simulation company, announces that Group turnover for the six months to 30 June 2020, which is currently generated entirely by the Group’s Simulation Division, is expected to be £2.5m (H1 2019: £3.1m). The shortfall is due to the effect of COVID-19 of the Group’s reseller sales, especially in the Chinese and European markets, which declined to £0.6m (H1 2019: £1.4m). REP_MED_130720_FINAL

July 13th, 2020|

Results of AGM

Intelligent Ultrasound (AIM: MED), the intelligent ultrasound software and simulation company, is pleased to announce that at the Annual General Meeting held at 11 a.m. today, all resolutions proposed were duly passed on a poll by shareholders. 18 June 2020_Results of AGM

June 18th, 2020|

Notice of AGM and publication of 2019 Annual Report

Intelligent Ultrasound Group plc (AIM: MED), the artificial intelligence software and simulation company, announces that the Company's Annual General Meeting ("AGM") will be held  at the Company’s registered office address, Cardiff Medicentre, Heath Park, Cardiff, CF14 4UJ on 18 June 2020 at 11:00 a.m. MED - Notice of AGM (18.05.20)

May 18th, 2020|

Director Dealings

Intelligent Ultrasound (AIM: MED), the intelligent ultrasound software and simulation company, announces that further to the Company's announcements on 17 April 2020 and 4 May 2020, certain Directors have, following Admission today, acquired a total of 409,523 Ordinary Shares in the Company via the Placing. MED - Director Dealings (06.05.20)

May 6th, 2020|